AMERICAN COLLEGE OF CLINICAL PHARMACY

Lobbying for AMERICAN COLLEGE OF CLINICAL PHARMACY

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 7, 2026

Expenses

$144,981.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

JOHN MCGLEW

Previously held: Senior Director, Government Affairs
KATHERINE D PHAM

Previously held: Senior Director, Policy and Professional Affairs

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 6

Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
Health Resources & Services Administration (HRSA)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 5

Pharmacy

Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.

Medicare/Medicaid

Promote enhanced quality, structure and information dissemination concerning medication therapy management services (MTMS) under Medicare Part D.

Health Issues

Promote greater medication safety and more appropriate medication use through more active involvement of pharmacists in patient care.

Education

Seek restoration of Medicare funding for specialized residency training under Medicare prospective payment rules. Seek pharmacist participation in National Health Service Corps (NHSC) loan repayment programs. Support development of inter-professional health education programs by working with Congress to make programs authorized under Title VII of the Public Health Service Act a significant aspect of comprehensive health professions education.

Medical/Disease Research/Clinical Labs

Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.